The SOSV Climate Tech Summit is Sept. 26-27.  Join now!
Post
Dec 21, 2022

SOSV’s IndieBio NY debuts new 25,000 sq. ft. office, lab and event space at 7 Penn Plaza in NYC

SOSV’s IndieBio NY has opened the doors to its new headquarters at 7 Penn Plaza—a 25,000-square-foot open office engineered to foster innovation and community in the New York deep tech ecosystem. The new facility will host startups in the IndieBio NY startup development program, which each year accepts 20+ pre-seed startups focused on human and […]

Recent news

Type
Trends
Programs
Category
Fortune Aug 22, 2023

SOSV GP & HAX Managing Director Duncan Turner named one of Fortune’s top 13 seed stage climate tech VCs

SOSV GP & HAX Managing Director Duncan Turner was named one of Fortune’s top 13 seed stage climate tech VCs to watch. Fortune noted how Turner “uses his design engineering background to help climate tech founders get their product to market—a core skill that can be especially challenging for founders when the market constitutes a […]

Bloomberg Jul 06, 2023

SOSV Founder Sean O’Sullivan tells Bloomberg what’s next in climate tech

SOSV Founder & Managing General Partner Sean O’Sullivan recently sat down with Bloomberg to discuss his storied career in climate tech and share his vision for the future of the all-important category. O’Sullivan has “quietly been one of the leading investors in the technology that could redefine what we eat, what we wear, how we […]

Post Apr 03, 2023

The 2023 SOSV Human Health 100

At SOSV, one of our core missions is the advancement of human health, and over the past decade or more we’ve pursued that mission in fields as varied as cancer therapeutics, CRISPR diagnostic platforms, assistive robotics, and remote healthcare, to name a few. More than 200 companies in our 1000+ company portfolio focus on health, and recently we sat down to rank our top 100, based on current as well as expected performance. The result is our first annual SOSV Human Health 100, which is presented below.

Post Feb 15, 2023

Solvay joins the Genesis Consortium to support SOSV’s IndieBio startups

Solvay Ventures, the venture capital fund of Solvay, announced that the fund has joined the Genesis Consortium to support startups in SOSV’s IndieBio startup development program, which holds a portfolio of early-stage, venture-backed companies innovating in planetary and human health. The Genesis Consortium, founded by SOSV and Mayfield, is a global alliance of venture capital firms and corporations dedicated to supporting […]

Post Jul 12, 2022

What the COVID-19 response revealed about deep tech startups in a time of crisis

When Covid hit, it wasn’t clear what the effect would be on our organization and portfolio.  Should we keep investing? Can we operate effectively? How will our startups respond? How can we help them? SOSV’s mission is to address the challenges of human and planetary health. And human health was calling. “In times of need, […]

The SOSV Human Health 100
Post Feb 22, 2022

The SOSV Human Health 100

At SOSV, one of our core missions is the advancement of human health, and over the past decade or more we’ve pursued that mission in fields as varied as cancer therapeutics, CRISPR diagnostic platforms, assistive robotics, and remote healthcare, to name a few. More than 200 companies in our 1000+ company portfolio focus on health, and recently we sat down to rank our top 100, based on current as well as expected performance. The result is our first annual SOSV Human Health 100, which is presented below.

Jun 21, 2021

ADM Joins the Genesis Consortium to Support Startups Powering the Future of Sustainable Innovation

Partnership to promote next-generation startups driving advancements at the intersection of sustainability, nutrition, health and wellness. ADM Ventures, the corporate venture capital arm of ADM, today announced its collaboration with the Genesis Consortium. Genesis, founded by Silicon Valley-based investors SOSV and Mayfield Fund, is a global alliance of venture capital firms and corporations dedicated to […]

The SOSV Climate Tech 100
Post May 04, 2021

Behind the numbers at SOSV’s Climate Tech 100

For more than a decade, SOSV’s founder and managing partner, Sean O’Sullivan, has been putting venture investing to work in support of climate tech startups.

Post Jul 15, 2020

SOSV’s IndieBio and Mayfield to Partner on Genesis Consortium for Life Sciences

Firms to invest $400 million in seed and early-stage funding over the next four years to propel the next tech revolution. In a move reflecting the shifting landscape of technology investing, SOSV and Mayfield are jointly doubling down on a commitment to early-stage life science startups. The effort, which they dub the “Genesis Consortium”, will provide a strong foundation […]